BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2027-02

126 industry Phase 2/3 trial readout(s) and 3 FDA decision event(s). Active trials only; estimated dates often slip.

← 2027-01 | 2027-03 →

FDA decision events

DateEventStatusCompanyDrugSource
2027-02-01 (month)PDUFA date (company-disclosed)pendingANAPTYSBIO, INC ANABPDUFA February 2027 - ANAPTYSBIO, INC
2027-02-28PDUFA date (company-disclosed)pendingApnimed, Inc. APMDPDUFA February 28, 2027 - Apnimed, Inc.
2027-02-28PDUFA date (company-disclosed)pendingPALVELLA THERAPEUTICS, INC. PVLAPDUFA February 28, 2027 - PALVELLA THERAPEUTICS, INC.

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2027-02 est.P1/P2Lumicell, Inc.NCT02584244 Feasibility of the LUM Imaging System for Detection of Gastrointestinal CancersColorectal Cancer; Pancreatic Cancer; Esophageal Cancer; Gastric Canceractive not recruiting66
2027-02 est.P1/P2AbbVie ABBVNCT04086264 IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid LeukemiaAcute Myeloid Leukemiaactive not recruiting218
2027-02 est.P1/P2Prevail TherapeuticsNCT04411654 Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)Gaucher Disease, Type 2active not recruiting7
2027-02 est.P3SK Life Science, Inc.NCT05219617 Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and AdultsSeizures; Lennox Gastaut Syndromerecruiting252
2027-02 est.P1/P2Day One Biopharmaceuticals, Inc.NCT05377996 A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsTriple Negative Breast Cancer; Breast Cancer; Endometrial Cancer; Ovarian Cancer; Fallopian Tube Canrecruiting360
2027-02 est.P3Gilead Sciences GILDNCT05382286 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally AdTriple Negative Breast Cancer; PD-L1 Positiveactive not recruiting443
2027-02 est.P1/P2SparingVisionNCT05748873 Promising ROd-cone DYstrophy Gene therapYRetinitis Pigmentosaactive not recruiting33
2027-02 est.P3CelltrionNCT05906992 A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple SclerosisRelapsing-remitting Multiple Sclerosisrecruiting512
2027-02 est.P1/P2Beijing Scitech-Mq Pharmaceuticals LimitedNCT06127238 Study of ST-1898 in Advanced Renal Cell CarcinomaAdvanced Renal Cell Carcinomaactive not recruiting90
2027-02 est.P1/P2Krystal Biotech, Inc. KRYSNCT06228326 A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the LungsLung Cancer, Non-small Cell; Lung Cancer Metastatic; Solid Tumor, Adult; Advanced Cancer; Lung Cancerecruiting250
2027-02 est.P2MediLink Therapeutics (Suzhou) Co., Ltd.NCT06241846 A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPCMetastatic Castration-resistant Prostate Cancer (mCRPC)recruiting100
2027-02 est.P3EMSNCT06268054 Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary DysmenorrheaPrimary Dysmenorrheanot yet recruiting78
2027-02 est.P3Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06323213 Efficacy and Safety Study of 610 in Patients With Severe AsthmaAsthmarecruiting480
2027-02 est.P2AbbVie ABBVNCT06365853 A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High FolRecurrent Ovarian Cancer; Folate Receptor-Alpha Positiveactive not recruiting108
2027-02 est.P2Eli Lilly and Company LLYNCT06413706 A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following RadiotherapyGliomaactive not recruiting45
2027-02 est.P2Genelux Corporation GNLXNCT06463665 Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerAdvanced Non-squamous Non-small-cell Lung Cancer; Advanced Squamous Non-Small Cell Lung Carcinoma; Mrecruiting142
2027-02 est.P2AbbVie ABBVNCT06524635 A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis ReceivinHidradenitis Suppurativa; Atopic Dermatitisrecruiting60
2027-02 est.P1/P2DualityBio Inc.NCT06554795 First-in-human Study of DB-1419 for Advanced/Metastatic Solid TumorsSolid Tumor, Adultrecruiting360
2027-02 est.P2AbbVie ABBVNCT06602479 A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic MigraineMigraineactive not recruiting309
2027-02 est.P260 Degrees Pharmaceuticals LLC SXTPNCT06656351 B-FREE Chronic Babesiosis StudyChronic Babesiosisrecruiting40
2027-02 est.P3Eli Lilly and Company LLYNCT06672549 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)Obesity; Overweightrecruiting125
2027-02 est.P2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06680947 A Phase IIb Study of 610 in Participants With Severe Eosinophilic AsthmaAsthmaactive not recruiting225
2027-02 est.P2Shandong New Time Pharmaceutical Co., LTDNCT06783257 Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer BleedingPeptic Ulcer Bleedingnot yet recruiting150
2027-02 est.P3Trust Bio-sonics, Inc.NCT06815627 Safety and Efficacy Evaluation of NH002 as a Contrast Agent in Subjects Undergoing Cardiac EchocardiographyCardiac Diseasesactive not recruiting150
2027-02 est.P2Bavarian NordicNCT06899802 A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV VaccineEncephalitisactive not recruiting411
2027-02 est.P3Eurofarma Laboratorios S.A.NCT06905210 Study of New Antiandrogenic Progestogen + Low-dose Estrogen for Moderate Acne VulgarisAcne Vulgaris; Acne Vulgaris on the Facerecruiting531
2027-02 est.P1/P2Arrowhead Pharmaceuticals ARWRNCT06937203 A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes MellitusObesity; Diabetes Mellitus, Type 2recruiting150
2027-02 est.P3CelltrionNCT06939595 A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung CancerNon Squamous Non Small Cell Lung Canceractive not recruiting225
2027-02 est.P2AbbVie ABBVNCT06972446 A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisRheumatoid Arthritisrecruiting180
2027-02 est.P3Kodiak Sciences Inc KODNCT06996080 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLEMacular Edema Secondary to Inflammationrecruiting300
2027-02 est.P3Fujian Shengdi Pharmaceutical Co., Ltd.NCT07060456 Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal InsulinType 2 Diabetesrecruiting300
2027-02 est.P3Keymed Biosciences Co.LtdNCT07106372 A Study of Stapokibatrt in Children Subjects With Atopic DermatitisAtopic Dermatitisnot yet recruiting240
2027-02 est.P1/P2AbCellera Biologics Inc. ABCLNCT07118891 Study Evaluating ABCL635 for Vasomotor Symptoms of MenopauseVasomotor Symptoms Associated With Menopause; Healthy Volunteersactive not recruiting136
2027-02 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT07136142 A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid TumorsMalignant Solid Tumorrecruiting150
2027-02 est.P1/P2GI Innovation, Inc.NCT07172802 A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid TumorsAdvanced Solid Tumor; Metastatic Solid Tumor; Non-small Cell Lung Cancer (NSCLC); Head and Neck (HNSrecruiting102
2027-02 est.P1/P2Qilu Pharmaceutical Co., Ltd.NCT07173556 A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast CancerAdvanced Breast Cancernot yet recruiting96
2027-02 est.P3Otsuka Pharmaceutical Co., Ltd.NCT07184645 A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic DermatitisAtopic Dermatitis (AD)not yet recruiting198
2027-02 est.P2Eli Lilly and Company LLYNCT07223840 A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid RelapseSmokingrecruiting222
2027-02 est.P2Suzhou HepaThera Biotech Co., Ltd.NCT07245953 A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus InfectionChronic Hepatitis Bactive not recruiting60
2027-02 est.P1/P2SovargenNCT07287202 Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or HemimegalenceFocal Cortical Dysplasia; Tuberous Sclerosis Complex (TSC); Hemimegalencephalyrecruiting12
2027-02 est.P2RDC Clinical Pty LtdNCT07315516 Sleep and Stress StudySleep Disorder (Disorder); Stress; Anxietyrecruiting240
2027-02 est.P2Candel Therapeutics, Inc. CADLNCT07332000 A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecProstate Cancer Patients Treated by Radiotherapy; Prostate Cancer (Adenocarcinoma)recruiting45
2027-02 est.P2Neurocrine Biosciences NBIXNCT07365462 Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive DyskinesiaTardive Dyskinesiarecruiting100
2027-02 est.P1/P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07367516 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal CancerEsophageal Cancerrecruiting105
2027-02 est.P1/P2Bond BiosciencesNCT07371793 A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary HemochromatosisHereditary Hemochromatosisrecruiting34
2027-02 est.P2Sanaria Inc.NCT07385287 Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe AdultsMalaria (Plasmodium Falciparum)recruiting180
2027-02 est.P2Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.NCT07395986 A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related CataractAge Related Cataractsactive not recruiting8
2027-02 est.P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT07464587 Evaluation of the Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Diseaserecruiting800
2027-02 est.P1/P2RIGImmune Inc.NCT07488897 RIG 101 Trial in Healthy Adults and Adults With AsthmaHealthy Adult Participants; Asthma Exacerbation; Safety and Efficacyrecruiting82
2027-02 est.P2Rivus Pharmaceuticals, Inc.NCT07491458 A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH - Metabolic Dysfunction-Associated Steatohepatitisrecruiting180
2027-02 est.P3Alcon Research ALCNCT07531043 Efficacy and Safety of FID 123472 Ophthalmic Solution for Ocular Redness in AdultsOcular Hyperemiarecruiting230
2027-02 est.P2Almirall, S.A.NCT07547813 A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis SuppurativaHidradenitis Suppurativarecruiting50
2027-02 est.P2TearSolutions, Inc.NCT07568730 A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep in Subjects With Neurotrophic KNeurotrophic Keratitisrecruiting54
2027-02 est.P2Enlivex Therapeutics Ltd. ENLVNCT07580716 Intra-Articular Allocetra in Patients With Primary Knee OsteoarthritisPrimary Knee Osteoarthritisrecruiting182
2027-02 est.P3TriGemX Bio, Inc.NCT07645924 A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of MigraineMigrainerecruiting1800
2027-02 est.P3Hangzhou Gensciences Biopharmaceutical Co., Ltd.NCT07663903 Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand TreatmentSevere Hemophilia Aactive not recruiting60
2027-02 est.P2Clarent Biopharma, Inc.NCT07706530 Oral CBP-0276 or Placebo in Adults With Active Psoriatic Arthritis (PsA)Arthritic Psoriasisnot yet recruiting240
2027-02 est.P2Shanghai RAAS Blood Products Co., Ltd.NCT07711158 A Phase II Exploratory Study of SR604 Injection Evaluating the Safety and Efficacy in the Treatment of Congenital Coagulation Factor VII DeficiencyFactor VII Deficiencynot yet recruiting12
2027-02 est.P2Antag TherapeuticsNCT07724340 A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and OverweighAdults With Overweight/Obesity and Type 2 Diabetesactive not recruiting150
2027-02 est.P2Liquidia Technologies, Inc. LQDANCT07748000 A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon AttacksRaynaud's Phenomenon Secondary to Systemic Sclerosisnot yet recruiting75
2027-02 est.P2Shandong Suncadia Medicine Co., Ltd.NCT07767513 Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular EventsLipoprotein Disorderrecruiting60
2027-02 est.P2Bausch & Lomb Incorporated BLCONCT07778888 BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution TrialDry Eye Diseaserecruiting20
2027-02 est.P3PT Bio FarmaNCT07854847 Study Interchangeability Hep-B Vaccine Administered at Birth DoseVaccination Adverse Event; Immunogenicity, Vaccinenot yet recruiting270
2027-02 est.P3ScandiBio Therapeutics ABNCT07889284 Combined Metabolic Activator Supplementation in Subjects Diagnosed With GoutGout Diseasenot yet recruiting336
2027-02-01 est.P2Novartis Pharmaceuticals NVSNCT02934568 Ribociclib (LEE011) Rollover Study for Continued AccessContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Canactive not recruiting22
2027-02-01 est.P1/P2Amplia Therapeutics LimitedNCT05355298 ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic CancerPancreatic Cancer; PDAC; Pancreatic Ductal Adenocarcinomaactive not recruiting62
2027-02-01 est.P1/P2Gracell Biotechnologies (Shanghai) Co., Ltd.NCT06530849 A Study of GC012F Injection in Subjects With Refractory Systemic Lupus ErythematosusRefractory Systemic Lupus Erythematosusactive not recruiting20
2027-02-01 est.P2AB Biotics, SANCT07193927 Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic TrialMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease; Fatty Liver Disease, Nonalcoholic;recruiting60
2027-02-01 est.P2Boryung Pharmaceutical Co., LtdNCT07373613 A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential HypertensionEssential Hypertensionnot yet recruiting330
2027-02-02 est.P2Novartis Pharmaceuticals NVSNCT04417621 Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic MelanomaMelanomaactive not recruiting134
2027-02-02 est.P2/P3Noema Pharma AGNCT05217628 An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.Trigeminal Neuralgiaactive not recruiting166
2027-02-02 est.P1/P2Vertex Pharmaceuticals Incorporated VERXNCT06185764 A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)Myotonic Dystrophy Type 1 (DM1)active not recruiting47
2027-02-02 est.P2Cellvax Therapeutics IncNCT06636682 FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate CancerProstate Cancer (Adenocarcinoma); Prostate CA; Prostate Cancers; Prostate Cancer (Post Prostatectomyrecruiting100
2027-02-03 est.P2InventVacc Biologicals Inc.NCT07743008 Phase 2 Trial of a Haemophilus Influenzae Serotype a (Hia) Glycoconjugate VaccineHaemophilus Influenzae; Haemophilus Influenzae Type aactive not recruiting47
2027-02-04 est.P3Hoffmann-La RocheNCT04657289 A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular AgeNeovascular Age-related Macular Degeneration (nAMD)active not recruiting451
2027-02-04 est.P3Janssen Research & Development, LLCNCT06741969 Nipocalimab in Moderate to Severe Sjogren's DiseaseSjogrens Syndromeactive not recruiting655
2027-02-04 est.P2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07521631 Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without DiabetesObesityrecruiting372
2027-02-04 est.P2Novartis Pharmaceuticals NVSNCT07811908 Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)Uncomplicated Plasmodium Falciparum Malariarecruiting120
2027-02-05 est.P2Bristol-Myers Squibb BMYNCT06946797 A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously UnNon-Small Cell Lung Canceractive not recruiting76
2027-02-05 est.P2Takeda TAKNCT07244263 A Study of Zasocitinib in Adults With Hidradenitis SuppurativaHidradenitis Suppurativaactive not recruiting91
2027-02-05 est.P1/P2Applied Biology, Inc.NCT07397325 Clinical Study of DA-020 for the Treatment of Chemotherapy Induced AlopeciaChemotherapy Induced Alopecia; Chemotherapy Side Effectsrecruiting60
2027-02-05 est.P2EktaHNCT07882654 A PHASE 2A, EXPLORATORY, RANDOMIZED, SINGLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY OF WEIGHT LOSS INDUCED BY NKS-3 IN OBESE ADULTS.Obesity / Overweight; Obesity (BMI Equal to or >30)not yet recruiting31
2027-02-07 est.P1/P2Intra-IMMUSG Pte LtdNCT07547228 A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)Neovascular Age Related Macular Degenerationrecruiting15
2027-02-08 est.P2AbcentraNCT06927739 Focused Orticumab Research for Treating Inflammation in Coronary ArteriesAcute Coronary Syndromes; Coronary Arterial Disease (CAD); Inflammation; Heart Disease; Myocardial Irecruiting240
2027-02-09 est.P2Aston Sci. Inc.NCT05771584 Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Gastric CancerGastric Canceractive not recruiting24
2027-02-09 est.P2Sanofi SNYNCT07170917 Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaHidradenitis Suppurativarecruiting208
2027-02-09 est.P2Regeneron Pharmaceuticals REGNNCT07175428 Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationAtrial Fibrillation (AF)recruiting1200
2027-02-10 est.P3Janssen Research & Development, LLCNCT06260163 A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative ColitisColitis, Ulcerativeactive not recruiting112
2027-02-10 est.P2AstraZeneca AZNNCT06271837 A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing TumorsAdvanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)active not recruiting127
2027-02-10 est.P2Shanghai Henlius BiotechNCT06349980 A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally AdvanCarcinoma, Hepatocellularrecruiting117
2027-02-10 est.P3Janssen Research & Development, LLCNCT06807424 A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic ArthritiArthritis, Psoriaticactive not recruiting813
2027-02-10 est.P3Takeda TAKNCT06973304 A Study of Teduglutide in Chinese Adults With Short Bowel SyndromeShort Bowel Syndromeactive not recruiting13
2027-02-11 est.P2Sanofi SNYNCT06984627 A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' DiseaseGraves' Diseaserecruiting30
2027-02-11 est.P2AstraZeneca AZNNCT07215702 A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.Sepsis; Acute Kidney Injuryrecruiting124
2027-02-11 est.P2Gan & Lee Pharmaceuticals.NCT07387003 Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 DiabetesType 2 Diabetes (T2DM)not yet recruiting345
2027-02-12 est.P2Merck Sharp & Dohme LLC MRKNCT03407144 Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)Hodgkin Lymphomaactive not recruiting340
2027-02-12 est.P3Ocugen OCGNNCT06388200 A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaRetinitis Pigmentosaactive not recruiting140
2027-02-12 est.P1/P2Jecho Biopharmaceuticals Co., Ltd.NCT07579741 A Study to Evaluate JL18008 in Subject With HIV Immunological Non-RespondersHIV Infectionsrecruiting30
2027-02-13 est.P3Epizyme, Inc.NCT04224493 A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo inRelapsed/Refractory Follicular Lymphoma; Follicular Lymphoma; Refractory Follicular Lymphomaactive not recruiting599
2027-02-13 est.P3SK Bioscience Co., Ltd.NCT07415252 SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 YearsVaricella (Chickenpox)recruiting780
2027-02-14 est.P1/P2Evopoint Biosciences Inc.NCT06987500 A Study of PARG Inhibitor XNW29016 in Patients With Advanced Solid Tumors Who Failed Standard TreatmentTumor, Solidrecruiting132
2027-02-14 est.P2Hudson BiotechNCT07437547 BPC 157 for Acute Hamstring Muscle Strain RepairHamstring Muscle Strain; Skeletal Muscle Injuryrecruiting120
2027-02-14 est.P2Hudson BiotechNCT07437560 Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental VitiligoNonSegmental Vitiligo; Nonsegmental Vitiligo (Stable)recruiting60
2027-02-14 est.P2Hudson BiotechNCT07437586 Topical GHK-Cu Gel for Acute Skin Wound HealingAcute Standardized Cutaneous Wounds (Punch-biopsy Wounds)recruiting60
2027-02-14 est.P1/P2Beijing BiotechNCT07467863 Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLCNon-Small Cell Lung Cancer; Advanced/Metastatic NSCLCrecruiting48
2027-02-14 est.P1/P2Beijing BiotechNCT07480213 Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)Small Cell Lung Cancer (SCLC); Relapsed/Refractory SCLC; SCLC, Extensive Stagerecruiting60
2027-02-14 est.P1/P2Beijing BiotechNCT07480928 Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal AdenocarcinomaPancreatic Ductal Adenocarcinoma (PDAC); Unresectable Locally Advanced or Metastatic Diseaserecruiting42
2027-02-14 est.P2Hudson BiotechNCT07481734 Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver DiseaseMetabolic Associated Steatotic Liver Disease; Nonalcoholic Steatohepatitis; Hepatic Steatosisrecruiting120
2027-02-14 est.P3Hudson BiotechNCT07481747 Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)Obesity; Overweight (Without Type 2 Diabetes) With Weight-related Comorbiditiesrecruiting2539
2027-02-14 est.P1/P2Beijing BiotechNCT07486089 Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)Breast Cancer (Locally Advanced or Metastatic); HER2-positive Breast Cancer; Triple-Negative Breast recruiting60
2027-02-14 est.P1/P2Hudson BiotechNCT07487363 TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVDAtherosclerotic Cardiovascular Diseases; Endothelial Dysfunctionrecruiting80
2027-02-14 est.P2Eisai Inc.NCT07493265 A Study to Evaluate the Efficacy and Safety of E2086 in Adults With NarcolepsyNarcolepsyrecruiting64
2027-02-14 est.P2Hudson BiotechNCT07505745 MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/ObesityPrediabetes; Insulin Resistance; Overweight/Obesityrecruiting120
2027-02-14 est.P1/P2Beijing BiotechNCT07589530 Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid TumorsAdvanced Solid Tumors; Metastatic Solid Tumors; TROP2-Expressing Solid Tumorsrecruiting60
2027-02-14 est.P1/P2Beijing BiotechNCT07744256 Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)Small Cell Lung Cancer (SCLC); Relapsed/Refractory SCLC; Extensive-stage SCLCrecruiting60
2027-02-15 est.P3Acerta Pharma BVNCT02972840 A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCLLymphoma, Mantle Cellactive not recruiting635
2027-02-15 est.P3Albireo, an Ipsen CompanyNCT05035030 Long-term Safety and Efficacy of Odevixibat in Patients With Alagille SyndromeAlagille Syndromeactive not recruiting62
2027-02-15 est.P3ModernaTX, Inc.NCT06592794 A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute GastroenteritisAcute Gastroenteritis; Norovirus Acute Gastroenteritisactive not recruiting37864
2027-02-15 est.P3CanSino Biologics Inc.NCT07017777 A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)Pneumococcal Infections; Streptococcal Infections; Bacterial Infectionsactive not recruiting600
2027-02-15 est.P1/P2Ikaria Bioscience Pty LtdNCT07245771 Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination Obesity &Amp; Overweightrecruiting104
2027-02-16 est.P3Bristol-Myers Squibb BMYNCT06140836 A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small CelCarcinoma, Non-Small-Cell Lungactive not recruiting190
2027-02-16 est.P3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07082114 A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusType 2 Diabetesrecruiting800
2027-02-17 est.P2Takeda TAKNCT06233461 A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseCrohn's Diseaserecruiting268
2027-02-17 est.P3Sanofi SNYNCT07424144 An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis Chronic Rhinosinusitis With Nasal Polypsactive not recruiting59
2027-02-17 est.P1/P2Beijing BiotechNCT07480954 Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Carcinoma; Recurrent or Refrrecruiting36
2027-02-17 est.P2Merck Sharp & Dohme LLC MRKNCT07486960 Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)Psoriatic Arthritisactive not recruiting140

← 2027-01 | 2027-03 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.